Extending the Donor Pool: Rehabilitation of Poor Organs

Thoracic Surgery Clinics

Volumn 25, Issue 1, 2015, Pages 27-33

  Cypel, Marcelo ^a   Keshavjee, Shaf ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ex vivo lung perfusion; Lung transplantation; Organ preservation

Indexed keywords

ADENOVIRUS VECTOR; BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TERBUTALINE; TISSUE PLASMINOGEN ACTIVATOR;

AIRWAY COMPLICATION; AIRWAY PRESSURE; BIOREACTOR; BLOOD CLOT LYSIS; BRAIN DEATH; CELL THERAPY; CLINICAL EVALUATION; CRYOPRESERVATION; DYNAMICS; EX VIVO LUNG PERFUSION; EX VIVO STUDY; EXTRACORPOREAL OXYGENATION; GENE THERAPY; HEALTH CARE UTILIZATION; HEART LEFT ATRIUM PRESSURE; HEART OUTPUT; HIGH RISK PATIENT; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; HUMAN; HYPOTHERMIA; IL 10 GENE; INTENSIVE CARE; LUNG DONOR; LUNG EDEMA; LUNG FUNCTION; LUNG LAVAGE; LUNG PERFUSION; LUNG REGENERATION; LUNG SCINTISCANNING; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MESENCHYMAL STEM CELL; METABOLOMICS; MICROARRAY ANALYSIS; MOBILE APPLICATION; NONHUMAN; ONCOTIC PRESSURE; ORGAN DONOR; ORGAN PRESERVATION; ORGAN RETRIEVAL; OXYGEN TENSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY REHABILITATION; REVIEW; SPECTROMETER; STATIC ELECTRICITY; VIRAL GENE DELIVERY SYSTEM; DONOR; METABOLISM; PERFUSION; PROCEDURES; TRANSPLANTATION;

BIOLOGICAL MARKERS; HUMANS; LUNG TRANSPLANTATION; ORGAN PRESERVATION; PERFUSION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84929942653     PISSN: None     EISSN: 15585069     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2014.09.002     Document Type: Review

References (51)

1. Punch J.D., Hayes D.H., LaPorte F.B., et al. Organ donation and utilization in the United States, 1996-2005. Am J Transplant 2007, 7:1327-1338.
2. Wigfield C.H., Love R.B. Donation after cardiac death lung transplantation outcomes. Curr Opin Organ Transplant 2011, 16:462-468.
3. Munshi L., Keshavjee S., Cypel M. Donor management and lung preservation for lung transplantation. Lancet Respir Med 2013, 1:318-328.
4. De Meester J., Smits J., Persijn G., et al. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001, 20:518-524.
5. Lederer D.J., Arcasoy S.M., Wilt J.S., et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:659-664.
6. Hopkinson D.N., Bhabra M.S., Hooper T.L. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant 1998, 17:525-531.
7. Fischer S., Matte-Martyn A., De Perrot M., et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001, 121:594-596.
8. Southard J.H., Belzer F.O. Organ preservation. Annu Rev Med 1995, 46:235.
9. Muller C., Hoffmann H., Bittmann I., et al. Hypothermic storage alone in lung preservation for transplantation: a metabolic, light microscopic, and functional analysis after 18 hours of preservation. Transplantation 1997, 63:625-630.
10. Pegg D.E. Organ preservation. Surg Clin North Am 1986, 66(3):617-632.
11. Carrel A., Lindbergh C.A. The culture of whole organs. Science 1935, 81:621-623.
12. Jirsch D.W., Fisk R.L., Couves C.M. Ex vivo evaluation of stored lungs. Ann Thorac Surg 1970, 10:163-168.
13. Steen S., Sjoberg T., Pierre L., et al. Transplantation of lungs from a non-heart-beating donor. Lancet 2001, 357:825-829.
14. Steen S., Liao Q., Wierup P.N., et al. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 2003, 76:244-252. [discussion: 252].
15. Steen S., Ingemansson R., Eriksson L., et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007, 83:2191-2194.
16. Rega F.R., Vanaudenaerde B.M., Wuyts W.A., et al. IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 2003, 24:20-28.
17. Rega F.R., Jannis N.C., Verleden G.M., et al. Long-term preservation with interim evaluation of lungs from a non-heart-beating donor after a warm ischemic interval of 90 minutes. Ann Surg 2003, 238:782-792.
18. Aitchinson J.D., Orr H.E., Flecknell P.A., et al. Functional assessment of non-heart-beating donor lungs: prediction of post-transplant function. Eur J Cardiothorac Surg 2001, 20:187-194.
19. Erasmus M.E., Fernhout M.H., Elstrodt J.M., et al. Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transpl Int 2006, 19:589-593.
20. Cypel M., Yeung J.C., Hirayama S., et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008, 27:1319-1325.
21. Petak F., Habre W., Hantos Z., et al. Effects of pulmonary vascular pressures and flow on airway and parenchymal mechanics in isolated rat lungs. J Appl Physiol (1985) 2002, 92:169-178.
22. Broccard A.F., Vannay C., Feihl F., et al. Impact of low pulmonary vascular pressure on ventilator-induced lung injury. Crit Care Med 2002, 30:2183-2190.
23. Cypel M., Rubacha M., Yeung J., et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009, 9:2262-2269.
24. Cypel M., Liu M., Rubacha M., et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009, 1:4ra9.
25. Yeung J.C., Koike T., Cypel M., et al. Airway pressure and compliance in the evaluation of donor lung injury during protective ex vivo lung perfusion in a porcine brain death model. J Heart Lung Transplant 2011, 30:S143.
26. Yeung J.C., Cypel M., Machuca T.N., et al. Physiologic assessment of the ex vivo donor lung for transplantation. J Heart Lung Transplantant 2012, 31:1120-1126.
27. Cypel M., Yeung J.C., Machuca T., et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 2012, 144(5):1200-1206.
28. Cypel M., Yeung J.C., Liu M., et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011, 364:1431-1440.
29. Levvey B.J., Harkess M., Hopkins P., et al. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplantant 2012, 12:2406-2413.
30. Kaneda H., Waddell T.K., de Perrot M., et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplantant 2006, 6:544-551.
31. De Perrot M., Sekine Y., Fischer S., et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002, 165:211-215.
32. Fisher A.J., Donnelly S.C., Hirani N., et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001, 163:259-265.
33. George T.J., Arnaoutakis G.J., Beaty C.A., et al. A physiologic and biochemical profile of clinically rejected lungs on a normothermic ex vivo lung perfusion platform. J Surg Res 2013, 183:75-83.
34. Koike T., Yeung J.C., Cypel M., et al. Kinetics of lactate metabolism during acellular normothermic ex vivo lung perfusion. J Heart Lung Transplantant 2011, 30:1312-1319.
35. Anraku M., Cameron M.J., Waddell T.K., et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. Am J Transplantant 2008, 8(10):2140-2148.
36. Kang C.H., Anraku M., Cypel M., et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant 2010, 30(3):289-298.
37. Ray M., Dharmarajan S., Freudenberg J., et al. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 2007, 7:2396-2405.
38. Das J., Kelley S.O. Protein detection using arrayed microsensor chips: tuning sensor footprint to achieve ultrasensitive readout of CA-125 in serum and whole blood. Anal Chem 2011, 83:1167-1172.
39. Bojko B., Gorynski K., Gomez-Rios G.A., et al. Low invasive in vivo tissue sampling for monitoring biomarkers and drugs during surgery. Lab Invest 2014, 94:586-594.
40. Van Raemdonck D., Neyrinck A., Cypel M., et al. Ex-vivo lung perfusion. Transpl Int 2014, [Epub ahead of print].
41. Warnecke G., Moradiellos J., Tudorache I., et al. Normothermic perfusion of donor lungs for preservation and assessment with the organ care system lung before bilateral transplantation: a pilot study of 12 patients. Lancet 2012, 380:1851-1858.
42. Mulloy D.P., Stone M.L., Crosby I.K., et al. Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function. J Thorac Cardiovasc Surg 2012, 144:1208-1215.
43. Frank J.A., Briot R., Lee J.W., et al. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007, 293:L52-L59.
44. Inci I., Ampollini L., Arni S., et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008, 27:1229-1236.
45. Karamanou D.M., Perry J., Walden H.R., et al. The effect of ex-vivo perfusion on the microbiological profile of the donor lung. J Heart Lung Transplant 2010, 29:S94.
46. Bonato R., Machuca T.N., Cypel M., et al. Ex vivo treatment of infection in human donor lungs. J Heart Lung Transplant 2012, 31:S97-S98.
47. Machuca T.N., Hsin M.K., Ott H.C., et al. Injury-specific ex vivo treatment of the donor lung: pulmonary thrombolysis followed by successful lung transplantation. Am J Respir Crit Care Med 2013, 188:878-880.
48. Yeung J.C., Wagnetz D., Cypel M., et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther 2012, 20:1204-1211.
49. Lee J.W., Fang X., Gupta N., et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A 2009, 106:16357-16362.
50. Ott H.C., Clippinger B., Conrad C., et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010, 16:927-933.
51. Petersen T.H., Calle E.A., Zhao L., et al. Tissue-engineered lungs for in vivo implantation. Science 2010, 329:538-541.